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Abstract
Particulate air pollution has been associated with respiratory and cardiovascular disease. Evidence for cardiovascular and
neurodegenerative effects of ambient particles was reviewed as part of a workshop. The purpose of this critical update
is to summarize the evidence presented for the mechanisms involved in the translocation of particles from the lung to
other organs and to highlight the potential of particles to cause neurodegenerative effects.
Fine and ultrafine particles, after deposition on the surfactant film at the air-liquid interface, are displaced by surface
forces exerted on them by surfactant film and may then interact with primary target cells upon this displacement.
Ultrafine and fine particles can then penetrate through the different tissue compartments of the lungs and eventually
reach the capillaries and circulating cells or constituents, e.g. erythrocytes. These particles are then translocated by the
circulation to other organs including the liver, the spleen, the kidneys, the heart and the brain, where they may be
deposited. It remains to be shown by which mechanisms ultrafine particles penetrate through pulmonary tissue and enter
capillaries. In addition to translocation of ultrafine particles through the tissue, fine and coarse particles may be
phagocytized by macrophages and dendritic cells which may carry the particles to lymph nodes in the lung or to those
closely associated with the lungs. There is the potential for neurodegenerative consequence of particle entry to the brain.
Histological evidence of neurodegeneration has been reported in both canine and human brains exposed to high ambient
PM levels, suggesting the potential for neurotoxic consequences of PM-CNS entry. PM mediated damage may be caused
by the oxidative stress pathway. Thus, oxidative stress due to nutrition, age, genetics among others may increase the
susceptibility for neurodegenerative diseases. The relationship between PM exposure and CNS degeneration can also be
detected under controlled experimental conditions. Transgenic mice (Apo E -/-), known to have high base line levels of
oxidative stress, were exposed by inhalation to well characterized, concentrated ambient air pollution. Morphometric
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analysis of the CNS indicated unequivocally that the brain is a critical target for PM exposure and implicated oxidative
stress as a predisposing factor that links PM exposure and susceptibility to neurodegeneration.
Together, these data present evidence for potential translocation of ambient particles on organs distant from the lung
and the neurodegenerative consequences of exposure to air pollutants.
Background
Particulate air pollution has been associated with acute
and chronic health effects due to respiratory and cardio-
vascular disease exacerbation [1,2]. New air quality stand-
ards have been introduced in Europe to control
particulate matter with an aerodynamic diameter less then
10 μm (PM10) [3]. However, particles in ambient air are a
complex mixture and might be quite diverse in terms of
their chemical composition and their sizes. In particular,
ultrafine particles (i.e., particles with diameters <100 nm)
represent a class of particles with health effects independ-
ent of PM10 [4]. Their nanosize results in high particle
density concentrations and large surface areas, relative to
their mass.
The cardiovascular and neurological effects of fine and
ultrafine particulate matter (PM) were discussed as part of
a workshop held in Munich in August 2004. The sympo-
sium was hosted by the GSF-National Research Center for
Environment and Health, the Research Focus Network
Health Effects of Aerosols and the HGF Environmental
Health Thematic Network. The symposium was organized
by Annette Peters, Institute of Epidemiology and Holger
Schulz, Institute for Inhalation Biology. The symposium
highlighted recent advancements in addressing the health
effects of fine and ultrafine particles on the cardiovascular
system as reviewed recently [2,5,6].
Evidence describing particle translocation from the lungs
has recently been summarized [7]. Interest in the non-pul-
monary targets of particulate air pollutants has been
increasing since the demonstration by Kreyling and others
that inhaled, nanosize particles quickly left the lungs and
were deposited in extra-pulmonary tissues [7,8]. The pos-
sibility that the brain was a potential target was raised in a
2002 editorial [9].
Experimental data was presented on how particles could
translocate from their initial pulmonary target site into
systemic circulation, and ultimately deposit in other
organ systems (e.g., brain). Further in two presentations
clinical and experimental evidence was given for neurode-
generation following PM exposure. The present critical
update discusses the evidence for potential mechanisms
for translocation of particles and their effects on the brain.
Translocation of fine and ultrafine particles in the lung
With each breath millions of particles enter the lungs,
where they may land on the surface of the airways or the
alveoli. Upon deposition, the processes of retention and
clearance begin. The fate of these particles depends on a
number of factors particularly the particle size but also the
anatomical location of the deposition in the airways or
alveoli, and the histological structures the particles inter-
act with at the site of deposition. The surfactant film is the
first structure encountered by the deposited particles. This
film lies at the air-aqueous liquid interface and covers the
whole internal surface of the respiratory tract. After parti-
cles deposit on the surfactant film, they are wetted and
displaced toward the epithelium by the surface forces gen-
erated at the interfaces between the air, particle and liquid
[10,11]. In addition to the surface tension forces, line ten-
sion at the 3-phase line between the particle, air and liq-
uid is likely important for particle wetting and
displacement. Surface and line tension forces depend on
the interfacial properties of the interacting systems,
including the particles themselves, the air and the sur-
rounding aqueous medium, with the interfacial film
between medium and particle [12]. Particle displacement
is the first step in the movement of the particles towards
the walls of the airways and alveoli. It has been shown
that smaller particles are more effectively displaced by a
fluid phase covered with a surfactant film than larger par-
ticles [10,11]. However, all particles which penetrate the
lung (PM10) are displaced by surface forces regardless of
their characteristics [13]. After deposition, other particle
characteristics such as shape, surface chemistry and the
solubility of the particles largely determine their fate. Of
particular importance for the generation of lung disease is
the residence time of the particles in the respiratory tract.
These surface and line tension forces determine whether
or not the particles are brought into close proximity with
the epithelial cells and the cells of the defence system,
including the macrophages on the epithelial layer, or with
dendritic cells at the base of the epithelium. Dendritic
cells push fine cytoplasmic processes up to the tight junc-
tions between the epithelial cells. (Figure 1, [14]). The
particle-cell interactions that result from the forces associ-
ated with the free energy of interfaces and dividing lines
may have implications for particle pathogenicity and the
persistence of small particles, in particular, i.e. ultrafine
particles or nanoparticles [15].Particle and Fibre Toxicology 2006, 3:13 http://www.particleandfibretoxicology.com/content/3/1/13
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We have postulated that during the initial step of reten-
tion, the particle may adsorb components of the sur-
factant film or are coated by it. This particle modification
may determine whether the particles are carried away free
or in macrophages up the airways by the mucociliary
action, or whether they are translocated into the tissue via
dendritic cells. These cells may process the particles and
carry them to the specific immunological defence system,
that is the particles are presented to T-lymphocytes where
they eventually initiate an immune reaction [16]. The
dendritic cells are called "sentinels" of the pulmonary
immune system because of their crucial role in pulmonary
defence [14,17]. In contrast to macrophages, which engulf
as much material as possible for efficient clearance, den-
dritic cells probably take up only as much antigen mate-
rial as necessary to stimulate an immune reaction with the
T-cells. The dendritic cells may cooperate with macro-
phages on the luminal side of the epithelium and with the
epithelial cells themselves. This mechanism may be
important for the trans-epithelial translocation of parti-
cles.
The surfactant film may primarily function as a defence
barrier, as its initial interaction with the particles is the
first step of a complex immunological cascade in the lung.
Particles are probably rendered less toxic and more attrac-
tive to phagocytic cells because of their modification by
the surfactant film or its components. Hence, we have
proposed that this modification is important for guiding
the particles along that clearance pathway which is most
beneficial for our health [16].
We have learned from epidemiologic studies hat ultrafine
particles may have a toxicological role [18]. They may
induce inflammatory and pro-thrombotic responses in
the organism, which could promote atherosclerosis,
thrombogenesis and the occurrence of cardiovascular
events. Furthermore, they may directly act on cells in var-
Schematic drawing of airway epithelial barrier with macrophages and dendritic cells, exposed to a fine particle (redrawn after  McWilliam et al., 2000) Figure 1
Schematic drawing of airway epithelial barrier with macrophages and dendritic cells, exposed to a fine particle (redrawn after 
McWilliam et al., 2000).
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ious organs inducing oxidative stress and eventually herit-
able mutations. They may also affect the autonomic
nervous system [5,19,20].
Whereas the uptake of fine particles (0.1–2.5 μm in diam-
eter) by macrophages is a specific ligand-receptor medi-
ated actin based process (phagocytosis) the uptake of
ultrafine particles (<0.1 μm in diameter) apparently
occurs by other, non-specific mechanisms. These mecha-
nisms include electrostatic, van der Waals and steric inter-
actions: They are subsumed under the term "adhesive
interaction" [21].
In order to study the non-specific mechanisms of particle
uptake macrophages in culture have been exposed to flu-
orescent polystyrene test particles of different sizes, 1 μm,
0.2 μm and 0.078 μm. In addition, the macrophages, after
having been treated with catochalasin D which depoly-
merises the actin network, have been exposed to the same
particle types. The actin-myosin sliding filament system is
one of the intracellular motility systems. The cell cultures
were investigated under a confocal laser scanning light
microscope Zeiss 510 META. The largest particles were
taken up by a large fraction of the cultured macrophages
(56% of the cells contained particles, SD 30%), but after
treatment with cytochalasin D this fraction was much
smaller (5%, 3%). There were only few macrophages
(21%, 11%) with particles of 0.2 μm in diameter, and
there were not less macrophages with particles after cyto-
chalasin D treatment (20%, 10%). However, there was a
substantial number of cells with ultrafine particles, with
(77%, 15%) and without (80%, 15%) catochalasin D.
These observations indicate that there is a particular
threshold in particle size with respect to particle uptake.
Particles with a diameter of 0.2 μm and smaller appear to
enter cells passively, that is by a mechanism which is dif-
ferent from phagocytosis. Larger particles are much more
avidly taken up by macrophages, but by the specific recep-
tor mediated, actin-dependent mechanism. Below the
particle size of 0.2 μm an increasing number of particles
enter the macrophages, but by the non specific mecha-
nisms mentioned above.
In order to elucidate the mechanisms regarding the pas-
sive uptake of particles, we conducted a control experi-
ment with erythrocytes. Erythrocytes do not possess
receptors at their outer surface and no intracellular actin-
myosin system. Therefore, erythrocytes are not expected to
take up particles. The exposure of erythrocytes to the same
particle types as in the previous experiments showed that
the 1 μm particles were not taken up at all, as expected,
but particles of smaller size entered the cells passively and
rapidly. This was confirmed by electron microscopy with
0.2 μm polystyrene and 0.02 μm TiO2 particles.
In additional experiments we conducted an inhalation
study with rats [22]. The lungs of rats which had inhaled
an aerosol of 0.02 μm TiO2 particles showed the following
results. (1) The particles could be found in all lung com-
partments 1 hour after inhalation, and the amount of the
particles found in a particular compartment was propor-
tional to the volume fraction of that compartment in the
lung. (2) The particle distribution was unchanged after 24
hours. (3) Some particles were found in erythrocytes
within the pulmonary capillaries.
These experiments demonstrated that ultrafine particles,
after deposition, are rapidly distributed into all tissue
compartments of the lung, and that these particles may
move between the tissue compartments. The particles
eventually reach the capillary lumen and may penetrate
into circulating cells and constituents, e.g. erythrocytes.
Thereby, they may be distributed into other organs of the
body, such as the liver, the heart, the kidneys and even the
brain [8,23]. However, in the present work we have dem-
onstrated that the way particles can be translocated to
other organs is by the circulating blood. It remains to be
shown by which mechanisms ultrafine particles penetrate
cellular membranes by non-specific means. We subsumed
these non-specific mechanisms under the concept of
"adhesive interactions", however, the exact mechanism
remains to be determined [22]. Particles which penetrate
into cells may reach specific organelles, they may reach
the nucleus and they may induce an oxidative burst
within the organelle's membranes where NADPH oxi-
dases are located. In addition they may induce the release
of inflammatory mediators and cytokines by the cells. All
these ultrastructural and ultrafunctional changes may
have potential health effects which deviate from "classi-
cal" inflammatory pathways and, therefore, should be
investigated in great detail. These findings described
above together with the observation of Oberdörster and
colleagues, who found evidence of translocation of
ultrafine particles into the brain [24] raises concern about
the potential impact of particles on the brain.
Currently it is unknown why some studies did not show
translocation from the lung to other organs [25,26]. How-
ever, there is the possibility that translocation of particles
may display a high variability within the population and
that factors such as diseases impact the translocation sub-
stantially. The health impact of long-term exposures to
particles on the individual is likely to be determined by
the number of particles and the amount of their surface
components that are translocated from the lung into the
body and by the velocity these particles and components
are cleared.Particle and Fibre Toxicology 2006, 3:13 http://www.particleandfibretoxicology.com/content/3/1/13
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Are particles a risk factor for Alzheimer's disease?
The neuropathological effects of PM entry into the CNS
tissues were first described in mongrel dogs [27]. In these
studies, histological evidence of chronic brain inflamma-
tion and an acceleration of Alzheimer's disease-like
pathology occurred, suggesting that the brain is also
adversely affected by air pollutants. Residents of Mexico
City, a metropolitan area with ozone and PM levels that
exceed the US air quality standards, exhibit evidence of
chronic inflammation of the upper and lower respiratory
tracts, alterations in circulating inflammatory mediators
[28] and breakdown of the respiratory epithelial barrier in
the nose [29].
We conducted a study using autopsy brain samples from
Mexican subjects, all lifelong residents of two large cities
with severe air pollution, Mexico City and Monterrey, and
five small cities with low levels of air pollution. Mexico
City (MC) is a megacity with 20 million inhabitants, 3.5
million vehicles and extensive industrial activity [30].
Monterrey is the second largest industrial city in the coun-
try with 3.5 million residents and thousands of industries.
Ozone (O3) and PM are the major air pollutants for both
Mexico City and Monterrey. Bacterial lipopolysaccharides
(LPS) and metals are major components of PM [30]. We
studied 19 subjects (n: 9 from low polluted towns, n: 10
from Mexico City and Monterrey). Autopsies were per-
formed 4.1 ± 1.3 h after death. All subjects were non-
smokers. Inclusion criteria included: 1) access to recent
complete clinical information within 3 months of death
through medical records, interviews with private practi-
tioners, and evaluation of job performance; 2) no evi-
dence of neurological disease or cognitive abnormalities
by medical history, and by complete neuropathological
examination; 3) negative family history of dementia; 4)
negative history of drug addictions, occupational expo-
sures to potential neurotoxicants, recent vaccinations, and
intake of vitamins, dietary or herbal supplements; and a
5) negative history of nonsteroidal anti-inflammatory
drugs (NSAID) and steroidal compounds. The subjects
had no clinical history or pathological evidence of short
or long-term inflammatory processes, administration of
anti-inflammatory drugs or hormones, or events such as
cerebral ischemia, head trauma or epilepsy.
We selected COX2 mRNA levels as the primary variable
because of the striking upregulation of COX2 immunore-
activity (IR) observed in the brains of dogs residing in
Mexico City [27,31] and because neuronal COX2 expres-
sion in the hippocampus is a function of the clinical pro-
gression of Alzheimer's disease (AD) [32]. COX2 mRNA
abundance was measured by real-time RT-PCR analysis of
total RNA isolated from frontal cortex and hippocampus.
In the 19 subjects for which frontal cortex tissue was avail-
able there was an elevation of COX2 mRNA levels in the
high exposure group (p = 0.009, Mann-Whitney test) (Fig-
ure 2A). There was an elevation of COX2 IR in the high
exposure group confirmed by quantitative image analysis
of COX2 IR (p = 0.01, Mann-Whitney test) (Figure 2B). In
the low exposure group, COX2 IR was confined to neuro-
nal cell bodies, whereas subjects from the high exposure
group exhibited strong COX2 staining of the endothelium
both in the cortex (Figure 2C) and white matter blood ves-
sels. In the 15 subjects for which hippocampus tissue was
available, COX2 mRNA was also elevated in the high
exposure group (p = 0.045, Mann-Whitney test) (Figure
2D). However, the average density of COX2 IR was not
significantly different from levels in low exposure group
(p = 0.3) (Figure 2E). Hippocampus COX2 IR in highly
exposed subjects was observed in neuronal bodies
included in the CA1–2 and CA4 regions and the dentate
gyrus, as well as endothelial cells (Figure 2F).
Aβ42 accumulation was examined in frontal cortex and
hippocampus because upregulation of COX2 expression
in dogs is associated with Aβ42 accumulation [31], and
because of reports of significant correlations between ele-
vated levels of Aβ42 and cognitive decline [33]. In subjects
from the high exposure group, Aβ42 selectively accumu-
lated in the perikaryon of pyramidal frontal neurons as
discrete granules and was present in cortical and white
matter astrocytes, and subarachnoid and cortical blood
vessels (Figure 3A and 3B). Quantitative estimation of
Aβ42 IR confirmed an increase in Aβ42 accumulation in
the frontal cortex (p = 0.04, Mann-Whitney test) (Figure
3C), and in hippocampus (p = 0.001, Mann-Whitney test)
(Figure 3D) of the high exposure group. Rare diffuse Aβ42
plaque-like staining was present in the frontal cortex of 3
subjects in the high exposure group (32, 38 and 43 years
old) (Figure 3E). The diffuse plaque-like staining was not
associated with the apolipoprotein E ε4 allele.
COX2 and Aβ42 IR were present in the olfactory bulb
from 3 subjects in the high exposure group and absent in
2 subjects from the low exposure group. The olfactory
bulb is the first synaptic relay of neurons that reside in the
olfactory epithelium and that are directly exposed to air
pollutants. Olfactory neurons are capable of taking up
and transporting environmental agents into the brain
[31,34]. The presence of olfactory bulb pathology in sub-
jects from the high exposure group suggests that the
human nose may be a portal of entry of air pollutants into
the brain [31].
Both chronic respiratory tract inflammation and break-
down of the nasal respiratory and olfactory barriers may
contribute to brain inflammation [31]. Respiratory tract
inflammation may play a role by chronically increasing
the levels of circulating cytokines that can cross the blood
brain barrier and evoke an inflammatory response [35].Particle and Fibre Toxicology 2006, 3:13 http://www.particleandfibretoxicology.com/content/3/1/13
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Increased concentrations of pro- and anti-inflammatory
serum cytokines are seen in Mexico City children along
with evidence of significant respiratory tract damage, and
breakdown of their nasal epithelial barriers [28,29].
Breakdown of epithelial barriers in the nose may contrib-
ute to brain inflammation by increasing the access of air
pollutants to the brain [31]. Although the subjects in the
high exposure group are chronically exposed to a complex
mixture of air pollutants, a variety of evidence suggests
that PM may play a role in the neuropathological findings
reported here. PM contains bacterial lipopolysaccharide
and combustion-derived metals such as nickel and vana-
dium [36] – all agents that are known to evoke inflamma-
tory responses [31,36]. Ultrafine (< 100 nm) PM, when
deposited in the lung, causes notable inflammation [37],
and ultrafine PM can be transported into the systemic cir-
culation [38]. A recent study shows that tobacco smoking,
a behavior that involves chronic high dose PM exposures,
is associated with a dose-dependent increase in the risk of
developing AD later in life [39], supporting an association
between PM exposure and neurological effects. The
pathology observed in the subjects chronically exposed to
severe air pollution has a number of similarities to the
pathology of AD. COX2 expression is elevated in the early
COX2 expression in frontal cortex and hippocampus Figure 2
COX2 expression in frontal cortex and hippocampus. (A and D) COX2 mRNA abundance was measured by RT-PCR and nor-
malized for 18s rRNA levels. Means ± SEMs are shown. COX2 mRNA was significantly elevated in the high exposure group in 
both frontal cortex (A, * p = 0.009) and hippocampus (D, * p = 0.04) from the high exposure group. (B and E) COX2 protein 
expression in sections of paraffin-embedded tissues was localized by COX2 immunohistochemistry (IHC) and the percent of 
tissue area that was immunoreactive (COX2 IR) was measured by quantitative image analysis. Means ± SEMs are shown. 
COX2 IR was significantly elevated in frontal cortex (B, * p = 0.01), but not in hippocampus (E) from the high exposure group. 
(C) Representative COX IHC in frontal cortex from a subject in the high exposure group showing strong staining of endothe-
lial cells in the capillaries (*), and pyramidal neurons (arrow), while other neurons were negative (arrowheads). Scale = 20 μm. 
(F) Representative COX IHC in dentate gyrus from a subject in the high exposure group showing COX2 positive neurons 
(arrowheads) and capillaries (short arrow). Scale = 15 μm.Particle and Fibre Toxicology 2006, 3:13 http://www.particleandfibretoxicology.com/content/3/1/13
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stages of Alzheimer's disease [40], intraneuronal Aβ42
accumulation in target areas precedes Aβ plaque deposi-
tion and neurofibrillary tangles [41-43], and olfactory
bulb pathology similar to that observed in the high expo-
sure group is one of the earliest pathological findings in
Alzheimer's disease [44], where it is associated with
impaired olfaction. The identification of COX2 upregula-
tion as an early marker of neuroinflammation in the con-
text of air pollutant exposure suggests that nonsteroidal
anti-inflammatory drugs (NSAIDs) may ameliorate the
neuropathological effects of exposure to air pollutants.
Our findings suggest that exposure to severe urban air pol-
lution is associated with brain inflammation and amyloid
deposits, causes of neuronal dysfunction that precede the
appearance of neuritic plaque formation and neurofibril-
lary tangles, hallmarks of Alzheimer's disease.
These findings in highly exposed individuals raise a cru-
cial issue: the role environment and air pollutants in par-
ticular play in the pathogenesis of neurodegenerative
diseases such as Alzheimer's. Although the number of
subjects was small due to the strict inclusion criteria, the
findings of this study concur with the acceleration of
Alzheimer's type pathology in Mexico City dogs [27,31].
These studies warrant additional forensic and epidemio-
logical studies supporting the association between
chronic exposure to air pollutants and the development of
Alzheimer's disease.
Aβ42 accumulation in frontal cortex and hippocampus Figure 3
Aβ42 accumulation in frontal cortex and hippocampus. Aβ42 was localized in sections of paraffin-embedded tissues by IHC. 
(A) Aβ42 IHC stained pyramidal neurons (p), astrocytes (arrows) and astrocytic processes (arrowheads) around blood vessels 
(*). (B) In addition to accumulation in pyramidal neurons (p) Aβ42 was deposited in smooth muscle cells (arrows) in cortical 
arterioles (*). A dead neuron surrounded by glial cells is indicated (arrowhead). (C and D) Quantitative image analysis of Aβ42 
IHC showed a significant increase in Aβ42 immunoreactivity (Aβ42 IR) in both frontal cortex (C, * p = 0.04) and hippocampus 
(D, * p = 0.001) in the high exposure group. (E) Aβ42 IHC of frontal cortex from a 38 year old subject from Mexico City 
showing diffuse plaque-like staining with surrounding reactive astrocytes (arrows). Scale = 20 μm.Particle and Fibre Toxicology 2006, 3:13 http://www.particleandfibretoxicology.com/content/3/1/13
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Currently, Alzheimer's disease is an irreversible, fatal
brain disorder that diminishes the quality of life of
affected individuals and places a burden on the health
care system [45]. In 2000 there were 4.5 million people
with AD in the US and it is projected that AD will affect
13.2 million by 2050 [45]. The role played by the environ-
ment in the pathogenesis of AD is unknown.
Neurodegeneration in Apo E-/- mice exposed to 
concentrated ambient particulate matter: influence of 
oxidative stress
A study was designed to assess the long-term impact of
concentrated ambient particles on various organ systems
of mice [46,47]. Detailed descriptions were published of
the experimental design [47] and modification of the
exposure system [48]. The observed effects ranged from
changes in heart rate (HR), heart rate variability (HRV),
atherosclerotic plaques on endothelia, gene expression,
and brain cell distributions [49-53].
In this study, histological changes suggestive of oxidative
stress-mediated damage were described including disrup-
tion of the blood-brain barrier, degeneration of cortical
neurons, apoptotic glial cells, and neurofibrillary tangles
and increases in NFκβ. Shortly after these reports were
published, we initiated an experimental study to deter-
mine if animals, transgenically predisposed to oxidative
stress (OS), would express neurodegeneration in response
to concentrated ambient particles (CAPs). A more exten-
sive description of this pathology and companion studies
on the enhanced cardiopulmonary toxicity have since
been published [53]. The Apo E deficient "knock out"
mouse (Apo E-/-) was used in this study because of numer-
ous reports describing heightened levels of OS and errors
in modulating OS in the brain [54-57]. Apo E-/- mice and
those from the normal C57BL/6 background strain, were
obtained commercially (Jackson Laboratory, Bar Harbor,
ME, USA) and exposed for 5 mo to concentrated north-
eastern regional (Tuxedo, NY, USA) ambient particles
(CAPs).
A cohort of C57BL/6 (C57) mice was used to investigate
effects on the respiratory system. Other cohorts, i.e. C57
(n = 6), and ApoE-/- mice, implanted with ECG transmit-
ters (DataScience), were used to investigate the effects of
CAPs on the cardiovascular system. A separate cohort of
double knockout mice (DK, ApoE and LDLr knockout)
was also included to investigate histopathological
changes and gene expression patterns of the cardiovascu-
lar and pulmonary systems. The overall mean concentra-
tion during the 30 hr/week CAPs exposure was 110 ± 79
μg/m3  (19.6  μg/m3  normalized annually). A modified
VACES [48] was used to expose mice at NYU's Sterling
Forest Laboratory to a ten-fold concentration of North-
eastern regional background CAPs daily for 6 hr/d, 5 d/wk
between Mar. and Sept. 2003.
Evidence for changes in autonomic function
A recently developed non-parametric statistical method
[58] was used to estimate the times that mean heart rates,
body temperature, and physical activity differed signifi-
cantly between the CAPs and sham exposed groups. CAPs
exposure most affected HR between 1:30 a.m. – 4:30 a.m.,
and the greatest effects were seen at the end of the 5-
month exposure. A two-stage modeling approach was
used to obtain the estimates of chronic and acute effects
on these three response variables. There were significant
decreasing patterns of HR (reaching a reduction of 33.8
beats/min in HR in CAPs exposed ApoE-/-mice compared
to air exposed ApoE-/- controls), body temperature, and
physical activity in ApoE-/- mice over the five months of
CAPs exposure, with smaller and non-significant changes
in C57 mice [52]. In addition, there was a 10 beats/min
per 100 μg/m3 decrease in HR during the exposure period
for the ApoE-/- mice that was not seen in the C57 mice.
At the same time, there was a quite different pattern of
change for HRV (SDNN and RMSSD) [50]. There was a
prolonged elevation, peaking at about two months into
the study, a decline to below the initial levels by 4
months, and a relatively modest change in the last month
of the exposure series. There were no effects seen in nor-
mal C57 mice exposed to the same atmospheres. The
response patterns indicated a perturbation of the homeo-
static function in the cardiovascular system with initial
stimulation (enhancement) and later depression of the
HRV parameters.
Evidence for progression of atherosclerosis
The lungs, the hearts, the aortas, the brains, and the upper
airways of all mice were harvested for histopathological
examination. The cross sectional area of the aorta root of
DK mice was examined morphologically using confocal
microscopy for the severity of lesion, extent of cellularity,
and lipid contents. Aortas from the arch to the iliac bifur-
cations were also sectioned longitudinally and lesion
areas were stained with Sudan IV [49]. All DK mice,
regardless of exposure, had developed extensive lesions in
the aortic sinus regions, with lesion areas that covered
more than 79% of the total area. In male DK mice, the
lesion areas in the aortic sinus regions appeared to be
enhanced by CAPs, with changes approaching statistical
significance (p = 0.06). In addition, plaque cellularity was
increased by 28% (p = 0.014, combined) whereas there
was no CAPs associated changes in the lipid content in
these mice.
When examining the entire aorta opened longitudinally,
both the ApoE-/- and DK mice had prominent areas ofParticle and Fibre Toxicology 2006, 3:13 http://www.particleandfibretoxicology.com/content/3/1/13
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severe atherosclerosis covering 40% or more of the lume-
nal surface. Visual examination of all images suggested
that plaques tend to form in clusters concentrating near
the aortic arch and the iliac bifurcations. Quantitative
measurements showed that CAPs exposure increased the
percentage of aortic intimal surface covered by grossly dis-
cernible atherosclerotic lesion by 57% in the ApoE-/- mice
(p = 0.03). Changes produced by CAPS in male (10%
increase) or female DK mice (8% decrease) were not sta-
tistically significant. Thus, subchronic exposure to CAPs in
mice prone to develop atherosclerotic lesions had a signif-
icant impact on the size, severity, and composition of aor-
tic plaque. Effects of CAPs on non-susceptible C57 were
minimal.
Evidence for oxidative stress in the brains
The brains of CAPs and air exposed Apo E-/- mice (6–9/
treatment) and C57BL/6 (5/treatment) were multi-
embedded (25 per slide), and serially sectioned in the
coronal plane. Slides were immunohistologically stained
for tyrosine hydroxylase (TH), a marker for dopamine
containing neurons and glial fibrillary acidic protein
(GFAP), a marker of astrocytic proliferation. The nuclei
reticularis and compacta of the substantia nigra (SN) are
anatomical regions which house dopaminergic neurons, a
population particularly sensitive to OS and predomi-
nantly damaged in human and animal models of Parkin-
son's neuropathy [59]. These regions were photographed
with a cool frame, Hamamatsu camera, digitized and
morphometrically analyzed by counting the total pixel
stained area of TH or GFAP stained cell bodies. Results
showed that quantitative analysis of the TH-stained neu-
rons and their fiber plexus showed no significant differ-
ences in the air or CAPs of exposed C57/blk6 relative to
the air exposed Apo E -/- animals. However, there was a
29% reduction in TH stained neurons in the CAPs
exposed relative to air exposed Apo E -/- mice (Figure 4).
In addition, a significant 8% increase (p < 0.05) in GFAP
staining (i.e., astrocytes) was measured in the nucleus
compacta of CAPs exposed Apo E -/- relative to air
exposed Apo E -/- brains. To examine possible mecha-
nisms behind the neurodegeneration seen in the CAPs
animals described above, immortalized mouse microglia
(BV2) cells were exposed to the same CAPs and examined
for cellular and genomic expressions of OS. The cultured
microglia responded with an initial oxidative burst and
mitochondrial depolarization, followed by a release of
inflammatory cytokines [53]. Universal microarrays of
microglial RNA indicated numerous OS pathways (Nfkb,
Toll receptor, glutathione etc.) were up-regulated after 2
hr exposure (Figure 5).
The present data suggest that controlled exposure to con-
centrated ambient air produces significant neurodegener-
ation in an animal model predisposed to OS (i.e., Apo E -
/-). The presence of OS markers in the CNS tissues of vic-
tims with amyolateral sclerosis, Parkinson's and Alzhe-
imer's has also been reported [60,61]. The possibility that
such neurodegenerative disorders may have an environ-
mental component cannot be excluded, especially in view
of the OS associated with certain environmental pollut-
ants (e.g., pesticides, metals, dioxides, PM). It is known
that PM particles are covered with biocontaminants and
other organic pollutants that contribute to the free radical
activity carried on the particles' surface. Contact with such
particles can damage lipids, nucleic acids, and proteins at
deposition sites within the lungs and in secondary targets.
The brain is vulnerable to OS because of its high energy
demands, low levels of endogenous scavengers (e.g., vita-
min C, catalase, superoxide dismutase, etc.), and high cel-
lular content of lipids and proteins. Certain neuronal
populations (such as the SN dopaminergic neurons) are
especially vulnerable to OS damage since they have
heightened energy demands due to their extensive synap-
tic fields and length of their fiber tracts [62]. The affected
populations in the present study were the dopaminergic
populations of the nigrostriatal pathway, the same popu-
lation targeted in Parkinson's disease [62,63].
Incidences of neurodegenerative diseases appear to be
increasing within the population [64] and raise the possi-
bility that environmental exposures, combined with sus-
ceptibility factors (e.g., genetics, diseased states,
malnutrition, etc.), might contribute to these increases.
Due to our cell culture data, we are confident to propose
that PM induced neurodegeneration is mediated by CNS
macrophages (i.e., microglia). The released reactive oxy-
gen species, which remain active in OS "compromised"
individuals, will in turn, damage OS vulnerable neurons
located in their microenvironment. In support of this is a
recent study which describes microglia-mediated, selec-
tive neurodegeneration to the dopaminergic neurons in a
primary CNS cultures exposed to nanometer sized parti-
cles from diesel engine exhaust [65].
Although it is possible that PM nanosize particles enter
the CNS olfactory bulb via olfactory tubercles, the biolog-
ical barriers (e.g., CO2:O2 interface, blood brain barrier
routes) encountered by the particles exiting the lungs and
entering the CNS are the more likely routes of entry to the
CNS neuropile. Damage to these endothelial barriers by
the free radical activity carried on the PM particle's surface
would disrupt the tight junctions and facilitate particle
translocation. In addition, new data suggest that PM neu-
rodegeneration might be initiated by innate immunity
pathways. Through such processes, inflammatory
cytokines, released in the periphery (e.g., respiratory epi-
thelia), can increase CNS levels of NF-κB activation and
up-regulate the innate immune receptor Toll-like receptor
2. Such activation and the subsequent events leading toParticle and Fibre Toxicology 2006, 3:13 http://www.particleandfibretoxicology.com/content/3/1/13
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neurodegeneration have recently been described in BALB/
c mice exposed to ambient Los Angeles particulate matter
[66]. Such data indicate a neuroimmunological pathway
to explain PM-CNS neurodegeneration. Together, these
reports confirm that the brain is a critical target of PM
exposure and implicate OS as a predisposing factor that
links PM exposure and neurotoxic susceptibility.
Conclusion
The data discussed as part of this critical update highlights
that ultrafine particles rapidly translocate from the lungs
into the cells and in particular into the blood. There is
mounting evidence that signs of oxidative stress can be
found in other organs, such as the heart [67] or the brain.
The results indicating that particles may contribute to the
overall oxidative stress burden of the brain is particularly
troublesome, as these long-term health effects may accu-
mulate over decades. The characteristics and sources of
particles responsible for the oxidative stress burden need
to be identified. In addition, further studies are needed in
humans to verify and quantify the relative risks for long-
term particle exposure on the onset of Parkinson's and
Alzheimer's disease. Both Parkinson's and Alzheimer's
disease are only diagnosed once manifest clinical signs
and symptoms are evident and impact the diseased per-
sons by long years of disabilities and diminished quality
of life.
Micrographs of the SN of (A) Air and (B) CAPs exposed Apo E -/- mouse brain and representative examples of the nucleus  compacta which house the dopaminergic neurons, vulnerable to OS Figure 4
Micrographs of the SN of (A) Air and (B) CAPs exposed Apo E -/- mouse brain and representative examples of the nucleus 
compacta which house the dopaminergic neurons, vulnerable to OS. Sections were taken from the same brain level. Neurons 
and astrocytes were immunocytochemical stained with TH and GFAP, respectively. A 29% reduction of TH staining and an 8% 
increase in GFAP was measured in the Apo E-/- PM exposed mice relative to air exposed Apo E-/- No differences in TH or 
GFAP bodies were observed in C57 Air or PM exposed animals. Sections 300× magnification.
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